Morvus Technology Limited is a privately owned pharmaceutical company specialising in the discovery and development of novel drugs and diagnostics for the oncology sector. It has offices near Brecon, Wales.
Morvus was formed in 2004 after the founders’ previous company, Enact Pharma plc, was acquired. Initially based on the Porton Down Science Park, near Salisbury, in 2007 the company relocated, with considerable assistance from the Welsh Government, to its present site.
The company has a diverse portfolio of oncology therapeutics and diagnostics and its lead drug is a potent anti-tumour agent that displays minimal toxicity to normal tissues and is rendered harmless in the circulation. Morvus is developing this drug as a potential treatment for lung cancer using an inhalation route to deliver the drug to tumour sites. The drug is also being assessed as a potential agent to treat some skin cancers.
Company Details
- Employees
- 5
- Founded
- -
- Phone
- 44 15 5866 8111
- in****@****vus.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- morvus.com
- Keywords
- Oncology drug research/development.
- Competitors
- Neurochase.
Morvus Technology Ltd Questions
Morvus Technology Ltd's helpline number is 44 15 5866 8111
Morvus Technology Ltd's website is morvus.com
Morvus Technology Ltd's LinkedIn profile is https://uk.linkedin.com/company/morvus-technology-ltd
Morvus Technology Ltd has
5 employees.
View email and phone details for 5
employees at Morvus Technology Ltd.
Morvus Technology Ltd's industry is
Pharmaceutical Manufacturing
Morvus Technology Ltd's top competitors are
Neurochase.
Morvus Technology Ltd's support email address is info@morvus.com
Morvus Technology Ltd's categories are Pharmaceutical Manufacturing
Morvus Technology Ltd's founding year is 2004
